Central Laboratories Solutions

  1. Starting A New Study? This One's For You 10/15/2025

    Choosing the right vendor at trial launch impacts costs, timelines, data integrity, and patient experience — yet vendor selection in clinical research remains fundamentally broken today.

  2. Data-Backed Recommendations For Primary Endpoints And I/E Criteria 10/23/2024

    Protocol SmartDesign is a first-of-its-kind solution that uses AI and trusted data to recommend successful trial elements, streamlining planning and accelerating development.

  3. The Path To Proof, Reimagined 5/15/2024

    By combining technology with clinical and operational expertise, Signant Health prioritizes the clinical research stakeholder experience, making it more intuitive, while ensuring the data journey is direct.

  4. Driving Success In Dermatology Drug Development

    Our dedicated teams are led by in-house, board-certified dermatologists who have decades of experience conducting early and late phase studies. Download the available datasheet to learn more.

  5. Optimizing The Trials Of The Future Today 8/23/2023

    Delve into how Signant Health's SmartSignals solutions and services effectively bolster decentralized clinical trials (DCTs) and the seamless execution of remote trial activities.

  6. Trial Results Summaries 10/5/2020

    TrialScope’s Trial Results Summaries (TrialSummaries.com) provides an unbiased and nonpromotional portal for sponsors to share plain-language summaries (PLS) with participants and the public

  7. Managing Execution Of A Phase III Clinical Trial 3/9/2026

    Clinical trials must accommodate operational challenges and changes in the market, which includes a sponsor's ability to forecast site activation, monitor resources, and track competitive activity.

  8. Clinical Pharmacokinetics And Pharmacometrics 4/11/2025

    Learn about a sophisticated suite of pharmacokinetic (PK) and pharmacometric services designed to accelerate and optimize early-phase drug development.

  9. Balancing Compliance Among The Shifting Sands Of Pharmaceutical Data Privacy Regulations 8/26/2022

    Maximize compliance, increase revenue potential, and improve patient safety by leveraging proven technology.

  10. Glioblastoma Multiforme 11/15/2022

    Medidata AI’s Synthetic Control Arm® (SCA®) leverages historical clinical trial data (HCTD) to provide a more relevant clinical insight for the purpose of developing new therapies.